Triple-negative breast cancer: molecular characteristics and potential therapeutic approaches
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0
Abstract
The term triple-negative breast cancer (TNBC) defines breast tumors that do not express estrogen receptors, progesterone receptor or epidermal growth factor receptor HER2 on immunohistochemical analysis. TNBC accounts for 12-17% of all types of breast cancer. Molecular profiling indicated that triple-negative breast cancer represents a heterogeneous subgroup of breast cancer. Triple-negative breast cancer shares histological and genetic abnormalities with basal-like subtype of breast cancer; however, this overlap is incomplete. Breast cancer found in BRCA1 mutation carriers is also frequently TNBC. Triple-negative breast cancer does not benefit from hormonal therapies or treatments targeted against HER2. The results of ongoing studies as well as the results of clinical trials suggest that poly(ADP-ribose) polymerase inhibitors, EGFR, Hedgehog, Notch, Wnt/β-catenin, VEGF signaling inhibitors, and mTOR, Src, and Bcr/Abl kinase inhibitors used alone or in combination with other anticancer drugs might be effective in triple-negative breast cancer treatment. In this review, current knowledge on molecular characteristics of triple-negative breast cancer and its subtypes’ treatment options is presented.
Authors and Affiliations
Maria Nowacka-Zawisza, Wanda Małgorzata Krajewska
Keywords
Related Articles
- EP ID EP67194
- DOI -
- Views 150
- Downloads 0
The role of YKL-40 in a cancerous process
YKL-40 is a secretory protein secreted among others by tumor cells and tumor-associated macrophages. Due to the structural homology this protein was classified to chitinases family CLP (chitinase – like protein) and to 1...
Czynne usuwanie leku z komórki jako jeden z mechanizmów oporności bakterii na środki przeciwdrobnoustrojowe i metody jego zwalczania
Pompy MDR stanowią powszechny mechanizm oporności wielu gatunków bakterii, polegający na transporcie poza komórkę m.in. leków, toksyn i środków dezynfekcyjnych i antyseptycznych. Pompy, których swoistość substratowa jest...
Rola limfocytów Th17 w patogenezie raka jelita grubego
Szacuje się, że rak jelita grubego (RJG) zajmuje pierwsze miejsce wśród przyczyn zgonów na nowotwory złośliwe u mężczyzn i kobiet w UE. Każdego roku w Polsce odnotowuje się 15 254 nowych przypadków RJG oraz 10 501 przypa...
Mobile antibiotic resistance – the spread of genes determining the resistance of bacteria through food products
In recent years, more and more antibiotics have become ineffective in the treatment of bacterial nfections. The acquisition of antibiotic resistance by bacteria is associated with circulation of genes in the environment....
Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival
Introduction: PIM-2 is a proto-oncogene that encodes for a serine/threonine kinase that interacts with various signaling molecules. PIM-2 is highly expressed in neoplastic tissues and in leukemic and lymphoma cell lines,...